Conference
Open access
Aug 2026
Nanoparticle-Based Drug Delivery Across the Blood–Brain Barrier: Current In Vivo Evidence, Translational Challenges, and Future Perspectives
This review critically evaluates recent advances in nanoparticle-mediated BBB targeting, focusing particularly on in vivo findings, and critically discusses the major barriers to clinical translation, including biosafety, manufacturing, and regulatory challenges.
A. Al-allaq, H. A. Hassan, Hidayet Hi̇dayet et al.
· Micro · 0 citations